Company: TELO
Filing Date: 2025-02-04
Form Type: 10-K
Source: 0001493152-25-004872
Chunk: 133

Company: Telomir Pharmaceuticals, Inc.
Filing Date: 2025-02-04
Form: 10-K
Item: Item 9C
Chunk 133
---
 be on an at-will
basis and can be terminated by either Mr. Aminov or our company at any time and for any reason. Under the agreement, Mr. Aminov will
receive a base salary of $0.275 million per year. In the event that Mr. Aminov’s employment is terminated by our company without
“Cause” or is terminated by Mr. Aminov for “Good Reason”, Mr. Aminov will be entitled to (1) be paid an amount
equal to Mr. Aminov’s annual base salary, which payment shall be made seventy-five percent (75%) in a lump sum within thirty (30)
days following the effective date of the general release of claims (following any revocation period) and twenty-five percent (25%) as
salary continuation payments in substantially equal installments over the six (6) months following the release effective date in accordance
with our customary payroll practices commencing on the first payroll date following the release effective date, and (2) receive twelve
(12) months’ accelerated vesting of any stock options that are outstanding and unvested as of such termination, such that any outstanding
and unvested stock options that would have vested during the twelve- (12) month period following the termination date had Mr. Aminov
remained employed in good standing shall become immediately vested and exercisable for a period of three (3) months post-termination
(subject to Mr. Aminov executing and delivering a customary general release in favor of the company). “Cause” is defined
in the agreement to include dishonesty, misappropriation, willful misconduct, breach of the agreement, and other customary matters. “Good
Reason” is defined to include a material adverse change in Mr. Aminov’s compensation or duties and level of responsibility.
The employment agreement also contains customary confidentiality and invention-assignment covenants to which Mr. Aminov is subject.

Michelle
Yanez, MBA

On
June 18, 2024, we entered into an employment agreement with Ms. Yanez, pursuant to which Ms. Yanez will serve as our Chief Financial
Officer. Under her employment agreement, Ms. Yanez has agreed to devote reasonable business time and effort to the business and affairs
of the Company. Ms. Yanez’ employment agreement provides that here employment can be terminated by either Ms. Yanez or our company
at any time and for any